Jain, T., Boland, T., & Vásquez, M. Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJain, Tushar, Todd Boland, and Maximiliano Vásquez. Identifying Developability Risks for Clinical Progression of Antibodies Using High-throughput in Vitro and in Silico Approaches. Taylor & Francis Group.
MLA (9th ed.) CitationJain, Tushar, et al. Identifying Developability Risks for Clinical Progression of Antibodies Using High-throughput in Vitro and in Silico Approaches. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.